- Home
- GRFS
GRFS
Grifols S.A.
as of 05-22-2026 3:38pm EST
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
| Founded: | 1940 | Country: | Spain |
| Employees: | 25247 | City: | N/A |
| Market Cap: | 5.4B | IPO Year: | N/A |
| Target Price: | $10.15 | AVG Volume (30 days): | 589.6K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $7.39 - $11.14 | Next Earning Date: | 07-28-2022 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 4.49% | Revenue Growth (next year): | 6.42% |
| P/E Ratio: | 18.67 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | +16.89% |
AI-Powered GRFS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare GRFS vs Leading Stocks
See how GRFS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GRFS Grifols S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.